Clinical Trials
2 trialsNCT00525057 2021-01-22
Dalteparin in Preventing DVT in Participants With Cancer
M.D. Anderson Cancer Center
Phase NA Completed
NCT02585713 2020-08-04
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Academic and Community Cancer Research United
Phase 3 Completed